1. A Novel Hemizygous Mutation of MAMLD1 in a Patient with 46,XY Complete Gonadal Dysgenesis
- Author
-
Birgit Köhler, Angela Hübner, Heiko Krude, Cigdem Cetingdag, Annette Grüters, Heike Biebermann, Maki Fukami, and Inge-Lore Ruiz-Arana
- Subjects
Genetics ,Embryology ,medicine.medical_specialty ,Mutation ,Endocrinology, Diabetes and Metabolism ,Gonadal dysgenesis ,Biology ,medicine.disease ,medicine.disease_cause ,Transactivation ,Endocrinology ,Hypospadias ,Hemizygote ,Internal medicine ,medicine ,Missense mutation ,Gene ,Testosterone ,Developmental Biology - Abstract
MAMLD1 is suggested to play a role in the development of 46,XY disorders of sexual development (46,XY DSD). So far, mutations in this gene have been detected in several cases of hypospadias with normal testosterone levels at birth. From in vitro studies it was concluded that Mamld1 might transiently affect testosterone synthesis during genital development. We describe the first MAMLD1 mutation in a 46,XY patient with complete gonadal dysgenesis. The novel MAMLD1 missense mutation (p.P677L) results in a severely reduced transactivation in vitro of the promoter of the MAMLD1 target gene HES3/Hes3. However, as knowledge about the functional role of MAMLD1 in gonadal development is limited, we suggest that additional factors (digenic or oligogenic cause) play a role in the development of complete gonadal dysgenesis in this patient.
- Published
- 2015
- Full Text
- View/download PDF